Circulatory MicroRNAs as Potential Biomarkers for Stroke Risk
Mens, M. et al. Circulatory MicroRNAs as Potential Biomarkers for Stroke Risk. Stroke. 2021 FEB 10 . https://doi.org/10.1161/STROKEAHA.120.031543
- Categories
- Abstracts
Mens, M. et al. Circulatory MicroRNAs as Potential Biomarkers for Stroke Risk. Stroke. 2021 FEB 10 . https://doi.org/10.1161/STROKEAHA.120.031543
Guerrero-Zotano, A., et al. Plk1 expression & efficacy of Palbociclib in advanced hormonal receptor-positive breast cancer patients from PEARL study (GEICAM 2012-03). Cancer Res February 15 2021 (81) (4 Supplement) PS2-01; DOI: 10.1158/1538-7445.SABCS20-PS2-01
Bustos, M. A., et al. Identification of cell-free microRNA signatures in pre-operative plasma from breast cancer patients. Cancer Res February 15 2021 (81) (4 Supplement) PS2-17; DOI: 10.1158/1538-7445.SABCS20-PS2-17
Garcia-Flores, M., et al. Isolation and Characterization of Urine Microvesicles from Prostate Cancer Patients: Different Approaches, Different Visions. Research Square 2021 FEB DOI 10.21203/rs.3.rs-183251/v1. Preprint
Sinnberg, T., et al. IgA autoantibodies target pulmonary surfactant in patients with severe COVID-19. medRxiv preprint doi: https://doi.org/10.1101/2021.02.02.21250940 this version posted Feb 5, 2020.
Snowhite, I., et al. Baseline Assessment of Circulating microRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Creation. Diabetes 2021 FEB; 70:638-651.
Precazzini, F. et al. Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis. Int. J. Mol. Sci. 2021, 22(3), 1176; https://doi.org/10.3390/ijms22031176
Frazzi, Raffael. BIRC3 and BIRC5: multi-faceted inhibitors in cancer. Cell & Bioscience 11, Article number: 8(2021)
Zhang, X., et al. Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study. Alimentary Pharmacology & Therapeutics . 2021; 53:432-442
Srour, M., et al. Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis. Breast J. 2021 JAN 19. Jan 19. doi: 10.1111/tbj.14119. Online ahead of print
Rocha, P., et al. CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. Cancer Immunol Immunother 2021. JAN 8 https://doi.org/10.1007/s00262-020-02820-4
Servetto, A., et al. A review of the use of Next Generation Sequencing methodologies to identify biomarkers of resistance to CKK4/6 inhibitors in ER+/HER2-breast cancer. Science Direct December 2020 DEC 9, 103191
Page last updated April 09, 2021